Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study

URN to cite this document:: urn:nbn:de:bvb:355-epub-446673
DOI to cite this document:: 10.5283/epub.44667

Hau, Peter ; Dirven, Linda ; Luerding, Ralf ; Beier, Dagmar ; Bumes, Elisabeth ; Reinert, Christiane ; Seidel, Clemens ; Bonsanto, Matteo Mario ; Bremer, Michael ; Rieken, Stefan ; Combs, Stephanie E. ; Herrlinger, Ulrich ; Seliger, Corinna ; Kuntze, Holger ; Mayer‑Steinacker, Regine ; Dieing, Annette ; Bartels, Claudius ; Schnell, Oliver ; Weyerbrock, Astrid ; Seidel, Sabine ; Grauer, Oliver ; Nadji‑Ohl, Minou ; Paulsen, Frank

; Weller, Michael ; Wick, Wolfgang

Preview

License: Creative Commons Attribution 4.0
PDF - Published Version
(750kB)

Date of publication of this fulltext: 02 Feb 2021 14:03

Alternative links to fulltext:DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

Background Combined radiochemotherapy followed by maintenance chemotherapy with cisplatin, lomustine and vincristine within the NOA-07 study resulted in considerable short-term toxicity in adult medulloblastoma patients. Here we investigated the long-term impact of this treatment, focusing on neurocognitive functioning and health-related quality of life (HRQoL). Methods Neurocognitive functioning ...